Robert Francis is listed as a director on 1 SEC Form D filing by 1 issuer in Jan 2016: Genomic Cancer Institute, Inc. (Tampa, FL — other health care — 2016).
What this means One deal on file with the SEC, filed Jan 2016. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Garry Latimer (1 shared filing), John Sauickie (1 shared filing), Matthew Miller (1 shared filing) and Steve Gorlin (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 5 bankruptcy cases matching the name listed in Key records below.
What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Robert Francis and found 4 differences: Robert Francis appears on 1 deal that stopped filing before reaching its target; Same name, different state: "Robert J. Francis" (CA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.